Immediate clinical outcomes in preterm neonates receiving antenatal magnesium for neuroprotection.

@article{Basu2011ImmediateCO,
  title={Immediate clinical outcomes in preterm neonates receiving antenatal magnesium for neuroprotection.},
  author={Sudeepta Kumar Basu and Vijay Chickajajur and Vivian F. L{\'o}pez and Alok Bhutada and Murali Krishna Dass Pagala and Shantanu Rastogi},
  journal={Journal of perinatal medicine},
  year={2011},
  volume={40 2},
  pages={185-9}
}
BACKGROUND Antenatal magnesium sulfate can potentially reduce the risk of cerebral palsy in neonates delivered between 24 and 32 weeks of gestational age. Some studies using high-dose magnesium sulfate for neuroprotection have reported increased perinatal mortality. METHODS A retrospective study was conducted on 475 neonates born between 24 and 32 weeks of gestational age. Serum magnesium level in the first 24 h of life was used to stratify the neonates treated with antenatal magnesium into… CONTINUE READING
13 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

Similar Papers

Loading similar papers…